Unapproved Weight Loss Drug Retatrutide Sparks Demand Despite Risks
Retatrutide, an unapproved weight loss drug, sparks demand despite risks, offering potential for non-responders to GLP-1 medications.
Study links air pollution and UV exposure to worse migraines
New study reveals air pollution and UV exposure worsen migraines—discover how climate change may intensify symptoms for 12%…
How Lifestyle Choices Can Slow Dementia
Discover how simple lifestyle changes can support dementia prevention by improving brain health, based on recent research of…
Injuries Rise in Youth Sports
Youth sports injuries rise, with physical therapy and time sometimes being a better option than surgery for knee…
Childrens Health Initiative Launched Nationwide Today
Learn about the childrens health initiative launched nationwide to tackle unhealthy toddler food ingredients and promote better health…
Medicare discount excludes some chronically ill patients
Medicare's new $50 GLP-1 drug discount excludes chronically ill patients like those with obesity or sleep apnea, leaving…
Hormone Replacement Therapy May Boost Brain Function
Hormone replacement therapy may boost brain function and prevent Alzheimer's disease in women with declining estrogen levels.
Phones harm children’s reading ability
New research reveals phones harm children's reading ability, even when unused, lowering test scores significantly.
Diet can alter your genetic expression
Discover how a plant-based diet can influence your genetic expression and impact essential bodily processes like metabolism and…
User Blocked from Online Platform
Research on preeclampsia and endometriosis in Black women yields no qualifying studies, highlighting a gap in medical knowledge…